i-addonfinal2
Kukuphi ukutya okucetyiswayo kuMhlaza?
ngumbuzo oqheleke kakhulu. IziCwangciso zeSondlo ezenzelwe wena kukutya kunye nezongezo ezenzelwe umntu ngamnye kwisalathiso somhlaza, imizila yemfuza, naluphi na unyango kunye neemeko zokuphila.

Ngaba izicatshulwa zamakhowa ziluncedo kumhlaza?

Oct 24, 2020

4.5
(43)
Ixesha lokufunda eliqikelelweyo: imizuzu emi-14
Ikhaya » blog » Ngaba izicatshulwa zamakhowa ziluncedo kumhlaza?

Iimbalasane

Amakhowa amayeza afana neTurkey Tail, iReishi kunye neMaitake mushroom isetyenziswe kwiindawo ezahlukeneyo zehlabathi. Uphononongo oluninzi kunye noluncinci lwezifundo zeklinikhi lubonisa amandla okucatshulwa kwiTurkey Tail/Yun Zhi/Coriolus versicolor amakhowa ukuphucula amajoni omzimba kunye/okanye ukusinda kwizigulana ezinomhlaza ezifana nebele, i-colorectal, i-gastric kunye nomhlaza wemiphunga kunye nokunciphisa umngcipheko womhlaza. njengomhlaza wesifo seprotate, kunye neReishi/Ganoderma lucidum mushrooms ukuphucula imisebenzi yamajoni omzimba kwizigulana ezinomhlaza kunye nokunciphisa umngcipheko we-cancer efana nomhlaza we-colorectal. Uphononongo lukwafumanise ukuba ngelixa ukonyuka kwedosi ye-Maitake mushroom extracts yonyusa ezinye iiparamitha ze-immunologic kwizigulana ezinomhlaza, icinezele abanye. Nangona kunjalo, izicatshulwa zamakhowa njengeTurkey Tail, Reishi kunye neMaitake azinakusetyenziswa njengomgca wokuqala umhlaza unyango, kodwa kuphela njenge-adjuvant ecaleni komgangatho wonyango emva kokufunda ukusebenzisana kwabo kunye neekhemotherapies ezithile. 


Isiqulatho ukufihla

Amakhowa amayeza eCancer (Reishi, Turkey Tail neMaitake)

Amakhowa asetyenziselwa amayeza asetyenziswe kwiindawo ezahlukeneyo zehlabathi, ngakumbi eAsia, kunyango lwezifo ezahlukeneyo. Ukuthandwa kwamakhowa amayeza njengolunye unyango okanye unyango oluncedisayo lukonyuke nakwizigulana ezinomhlaza ukusukela kwiminyaka emininzi. Ngapha koko, e-China nase-Japan, amakhowa amayeza avunyiwe njengezincedisi ecaleni komgangatho wabo wokhathalelo lwe-chemotherapy kwizigulana ezinomhlaza ngaphezulu kweshumi leminyaka. 

umsila we-turkey, ganoderma lucidum, maitake mushroom womhlaza

Zingaphezu kwe-100 iintlobo zamakhowa ezisetyenziselwa ukunyanga izifo ezahlukeneyo kubandakanya umhlaza eAsia. Imixube ye-bioactive ekhoyo kuhlobo ngalunye lwamakhowa amayeza yahlukile kwaye kungoko ine-bioactivities ezahlukeneyo. Eminye yemizekelo eqhelekileyo yamakhowa athandwa kakhulu kukudibana nokunyanga komhlaza Amakhowa engonyama, Agaricus blazei, Cordyceps sinensis, Grifola frondosa / Maitake, Ganoderma lucidum / Reishi, kunye neTurkey Tail.

Kodwa ngaba sinezifundo eziphakamisa ukuba kubandakanya la makhowa njengenxalenye ye Ukutya kwabaguli abanomhlaza Ngaba unokuphucula iziphumo zomhlaza okanye uncede ukunciphisa umngcipheko womhlaza? Ngaba singawasebenzisa la makhowa njengonyango lokuqala lomhlaza?

Masifumanise kolunye lwezifundo zeklinikhi kunye nokujonga okunxulumene namanye ala makhowa, ngakumbi iTurkey Tail / Yun Zhi / Coriolus versicolor Mushrooms, Reishi / Ganoderma lucidum Mushrooms kunye neMaitake / Grifola frondosa mushroom.

Ukusetyenziswa kwamakhowa kunye neCancer Prostate 

Isifundo kubemi baseJapan

Kuphononongo lwakutsha nje olupapashwe kwi-2020, abaphandi abavela kwiSikolo iYunivesithi yaseTohoku seMpilo kaRhulumente kunye neYunivesithi yaseTohoku isidanga seSayensi yezoLimo eJapan nasePennsylvania State University kunye neZiko loPhando laseBekman kwiSixeko seThemba e-US bavavanya ubudlelwane phakathi kokusebenzisa amakhowa kunye nesifo somhlaza wesibeletho. Basebenzise idatha yokutya kwiMiyagi Cohort Study ngo-1990 kunye no-Ohsaki Cohort Study ngo-1994, ebandakanya amadoda angama-36,499 aneminyaka ephakathi kwama-40-79 eminyaka. Ngexesha lokulandelwa kweminyaka eyi-13.2, amatyala angama-1204 ewonke omhlaza wesibeletho axeliwe. (UShu Zhang okqhubekayo, Int J Cancer., 2020)

Uphononongo lufumanise ukuba xa kuthelekiswa nabathathi-nxaxheba abatya amakhowa ngaphantsi kwenkonzo enye ngeveki, abo babewatya amakhowa rhoqo babedityaniswa nomngcipheko wokuhla komhlaza webala. Unciphiso lomngcipheko lwalimalunga ne-8% kwabo batya i-1-2 yeenkonzo ngeveki kunye ne-17% kwabo basebenzisa ii-≥3 zeenkonzo ngeveki. Olu phononongo lukwabonakalise ukuba lo mbutho ubaluleke kakhulu kumadoda aseJapan aneminyaka yobudala ephakathi kunye nabadala. 

Ngokusekwe kwezi zinto zifunyanisiweyo, abaphandi bagqiba kwelokuba ukutya amakhowa rhoqo kunokunceda ukunciphisa umngcipheko womhlaza webele.

Impembelelo yeQhosha eliMhlophe leMushroom (WBM) Ukufakwa kwepowder kumanqanaba e-serum Prostate Specific Antigen

Abaphandi abavela kwiZiko lezeMpilo leSizwe leZiko lezeMpilo kunye ne-Beckman Research Institute yeSixeko saseThemba eCalifornia baqhuba isifundo ukuvavanya iziphumo zeqhosha elimhlophe le-mushroom powder kwi-serum Prostate Specific Antigen level. Olu pho nonongo lubandakanya izigulane ezingama-36 ezipheleleyo ngokunyuka kwamazinga e-PSA. (Przemyslaw Twardowski, et al, Umhlaza. 2015 Sep)

Uphononongo lufumanise ukuba emva kweenyanga ezi-3 zeqhosha elimhlophe lokutya ngomgubo, amanqanaba e-PSA ancitshisiwe kwizigulana ezili-13 kwezi-36. Ireyithi yokuphendula ye-PSA iyonke yayiyi-11% ngaphandle kwethamo lokuthintela iposi kusetyenziswa umhlophe iqhosha lomgubo wekhowa. Kwizigulana ezibini ezifumene i-8 kunye ne-14 gm / usuku lweqhosha elimhlophe le-mushroom powder, impendulo epheleleyo enxulumene ne-PSA yaqwalaselwa, kunye ne-PSA yenqabile kumanqanaba angabonakaliyo kwiinyanga ezingama-49 ukuya kwezingama-30 nakwezinye izigulana ezibini ezafumana i-8 ne-12 gm / ngosuku, impendulo encinci yaqwalaselwa. 

Ubungqina-Ngokwenzululwazi iSondlo esenziwe ngobuNtu seCancer Prostate | addon.ubomi

Ukusetyenziswa kweMushroom kunye noMngcipheko weTotali kunye noMhlaza oKhethekileyo weSiza kubemi baseMelika 

Kuphononongo olupapashwe ngo-2019, abaphandi abavela eHarvard TH Chan School of Public Health, Brigham and Women's Hospital kunye neHarvard Medical School eBoston kunye neYunivesithi yaseDongguk eMzantsi Korea bavavanya umanyano lokusetyenziswa kwamakhowa kunye nomngcipheko ohlukeneyo womhlaza womhlaza. Ukuphonononga, basebenzise idatha evela kubafazi abangama-68,327 abasuka kwiSifundo sezeMpilo sabaBongikazi (1986-2012) kunye namadoda angama-44,664 asuka kuFundo lokuLandelwa kweeNgcali zezeMpilo (1986-2012) umhlaza ngexesha lokugaya. Ngexesha lokulandelwa okuphakathi kweminyaka eyi-26, zizonke iimeko zomhlaza ze-22469 zaxelwa. (Dong Hoon Lee et al, Cancer Prev Res (Phila)., 2019)

Olu pho nonongo alufumananga nxu lumano phakathi kokusetyenziswa kwamakhowa kunye nomngcipheko wee-cancer ze-16 zesiza esithile kubantu base-US nabesilisa. Abaphandi bacebisa ngakumbi ukuba liqela / izifundo ezisekwe kubemi ukuvavanya umbutho wokutya amakhowa kunye neentlobo ezithile zomhlaza kumacandelo ohlukeneyo obuhlanga / amaqela eentlanga.

Ukutya okuTyiwa emva kokuChongwa koMhlaza!

Akukho mhlaza mibini ifanayo. Yiya ngaphaya kwezikhokelo zesondlo esiqhelekileyo kuwo wonke umntu kwaye wenze izigqibo ezizezakho malunga nokutya kunye nezongezo ngokuzithemba.

I-Turkey Tail / Yun Zhi / Coriolus ngokuchasene neeMushroom

Umsila waseTurkey / iCoriolus ngokuchasene namakhowa akhula kwiilogo ezifileyo. Izicatshulwa zabo zonyango ziveliswa kwi-mycelium kunye neziqhamo zomzimba we-mushroom kwaye zisetyenziselwa abaguli abanomhlaza ukuphucula amajoni abo omzimba. Izithako eziphambili yi-beta-Sitosterol, i-Ergosterol kunye ne-polysaccharopeptides ezibandakanya iPolysaccharide krestin (PSK) kunye nePolysaccharide peptide (PSP) efunyenwe kwi-mycelium ye-CM-101 kunye ne-COV-1 ye-fungus, ngokulandelelana.

Impembelelo yeTurkey Tail / Yun Zhi / Coriolus versicolor Ukusetyenziswa kweMushroom kuMhlaza 

Isifundo saseHong Kong 

Abaphandi abavela kwiYunivesithi yaseTshayina i-Hong Kong, kunye ne-Prince of Wales Hospital eHong Kong benze uhlalutyo lweemeta ukuhlalutya ukusebenza kweTurkey Umsila / iYun Zhi / iCoriolus ngokuchaseneyo nokusetyenziswa kwamakhowa ekusindeni kwabaguli abanomhlaza kwizilingo ezili-13 zeklinikhi ezifunyenwe kwikhompyuter. isiseko sedatha kunye nophando olwenziwayo. (Wong LY Eliza okqhubekayo, Pat yakutshanje yeAllergy Drug Discov., 2012)

Uphononongo lufumanise ukuba abaguli abasebenzisa amakhowa eTurkey Tail kunye nonyango lwabo oluqhelekileyo lomhlaza babenokuphucuka okubonakalayo ekusindeni, kunye nokuncitshiswa okupheleleyo kwe-9% yokufa kweminyaka emi-5, xa kuthelekiswa nabo bathatha kuphela unyango oluqhelekileyo lokulwa nomhlaza. Iziphumo zazibonakala kwizigulana ezinomhlaza wamabele, umhlaza esiswini, okanye umhlaza wecolorectal ophathwe nge-chemotherapy, kodwa hayi kwi-esophageal kunye nasopharyngeal cancer. 

Olu phononongo alunakuqinisekisa ukuba loluphi unyango oluchasene nomhlaza olunokunyusa isibonelelo esivela eTurkey Tail / Yun Zhi / Coriolus versicolor mushroom.

Iziphumo zeTurkey Umsila wokuSetyenziswa kweMushroom kwizigulana ezinomhlaza wamabele

Kwisifundo esenziwe ngabaphandi abasuka kwiYunivesithi yaseMinnesota e-US, baqhuba isigaba esincinci sokuqala sonyango kwizigulana ezili-1 zomhlaza wamabele abagqibe unyango ngemitha ukumisela idosi ephezulu yokunyamezelwa kweTurkey Umsila wamakhowa xa uthathwa yonke imihla yahlulwe idosi yeeveki ezi-11. I-6 kwezi-9 zezigulana ezinomhlaza wamabele ezifumene i-11 g, 3 g, okanye i-6 g yeTurkey Tail Mushroom yokulungiselela isicatshulwa sigqibe isifundo. (UCarolyn J Torkelson okqhubekayo, ISRN Oncol., 9)

Uphononongo lwafumanisa ukuba ukuya kuthi ga kwi-9 grams / ngosuku lwe-Turkey Tail Mushroom extract yokulungiselela ikhuselekile kwaye iyanyamezeleka kwezi zigulana zomhlaza wamabele xa zinikwa isithuba sabo sesiqhelo. umhlaza unyango. Baye bafumanisa ukuba ukulungiswa kwesicatshulwa se-mushroom kunokuphucula isimo somzimba sokuzivikela kwizigulana ezinomhlaza wesifuba ezilandela unyango olusisiseko lwe-oncological. Nangona kunjalo, izifundo zeklinikhi eziyilwe kakuhle ngakumbi ziyafuneka ukuseka ezi ziphumo.

Impembelelo yeTurkey Tail Mushroom Ingredient / Polysaccharide krestin (PSK) kwiiColorectal Cancer Patients

Uphononongo olwenziwe siSibhedlele iFukseikai eJapan, abaphandi bathelekisa iminyaka eli-10 yokusinda kwizigulana ezinomhlaza we-colorectal owenziwa utyando, phakathi kwabo baguli bafumana iqela ngomlomo i-fluoropyrimidines kuphela kunye nabo bafumana i-oral fluoropyrimidines ngokudibeneyo ne-Polysaccharide kureha / Polysaccharide krestin (PSK), isithako esiphambili seTurkey Tail mushroom, iinyanga ezingama-24. Bafumanise ukuba i-10 yeminyaka yokuphila kwabaguli abafumene i-PSK kunye nonyango lwabo yayiyi-31.3% ephezulu kunabo bafumana unyango bodwa. Kwiimeko ezinobungqingili obunokuhlasela okuphezulu kwe-lymphatic kunye ne-venous (umhlaza ongena ngaphaya kodonga lwamathumbu), ukuphucuka kokusinda ngokubanzi kwakuyi-54.7% eyayibaluleke nangakumbi. (UToshimi Sakai okqhubekayo, iCancer Biother Radiopharm., 2008)

Olunye uphononongo olwenziwe ngabaphandi abavela kwiYunivesithi yaseGunma, eJapan bakwafumene izibonelelo ezifanayo zeproteyascharide K eboshwe ngeprotein xa ithathwa kunye nonyango lomhlaza i-tegafur kwizigulana ezinomhlaza wesigaba II okanye III somhlaza. (USusumu Ohwada okqhubekayo, u-Oncol Rep., 2006)

Impembelelo yeTurkey Tail Mushroom Ingredient Polysaccharide krestin (PSK) kwizigulana ezinomhlaza wesisu

Uhlalutyo lweemeta olwenziwe ngabaphandi beYunivesithi yaseGraduate School of Medicine bavavanya isiphumo se-immunochemotherapy ekusindeni kwizigulana ezinomhlaza wesisu esiswini ezingama-8009 ezenziwa utyando, ukusuka kwizilingo eziyi-8 ezilawulwa ngononophelo. Kolu phando bathelekisa iziphumo ze-chemotherapy kunye ne-immunotherapy zisebenzisa i-Turkey Tail Mushroom Ingredient-Polysaccharide krestin (PSK) - njenge-immunopotentiator. (UKoji Oba okqhubekayo, iCancer Immunol Immunother., 2007)

Iziphumo ezivela kuhlalutyo lwe-meta zicebise ukuba i-adjuvant immunochemotherapy kunye nePolysaccharide krestin (PSK), eyona nto iphambili eTurkey Umsila we-mushroom, inokuphucula ukusinda kwabaguli abanomhlaza esiswini abaye benza utyando.

Impembelelo yeTurkey Tail Mushroom Ingredient Polysaccharide krestin (PSK) kwizigulana ezinomhlaza wemiphunga

Abaphandi abavela kwiKholeji yaseCanada yaseNaturopathic Medicine kunye neOttawa Hospital Research Institute eCanada benze uphononongo olucwangcisiweyo lwePolysaccharide krestin (PSK), eyona nto iphambili eTurkey Tail mushroom, kunyango lomhlaza wemiphunga. Inani elipheleleyo leengxelo ze-31 ezivela kwizifundo ze-28 (i-6 engahleliwe kunye ne-5 yezilingo ezilawulwa ngokungacwangciswanga kunye nezifundo ezili-17 zangaphambili) zisetyenziselwe uhlalutyo olufunyenwe ngophando loncwadi kwi-PubMed, EMBASE, CINAHL, kwiThala leencwadi laseCochrane, kwiAltHealth Watch, kunye Ithala lencwadi lezeNzululwazi kunye neTekhnoloji kude kube ngu-Agasti 2014. (Heidi Fritz okqhubekayo, Umanyano lweCancer Ther., 2015)

Olu phononongo lufumene ukuphucuka kokusinda okuphakathi kunye ne-1-, 2-, kunye ne-5 yeminyaka yokusinda kuvavanyo olulawulwa ngokungenamthetho ngokusetyenziswa kwePSK. Uphononongo lufumene izibonelelo kwiiparameter zomzimba kunye nokusebenza kwehematological / igazi, imeko yokusebenza kunye nobunzima bomzimba, iimpawu ezinxulumene nethumba ezinjengokudinwa kunye neanorexia, kunye nokusinda kwizilingo ezilawulwa ngokungahleliwe. 

Abaphandi bagqiba kwelokuba iPolysaccharide krestin (PSK), eyona nto iphambili eTurkey Umsila we-mushroom, inokuphucula ukusebenza kwamajoni omzimba (okwandisiweyo kombulali wendalo). Nangona kunjalo, uvavanyo olukhulu lweklinikhi oluchazwe kakuhle luyafuneka ukumisela ezi zinto zifunyanisiweyo.

Amakhowe kaReishi / Ganoderma lucidum

Amakhowa eReishi / Ganoderma lucidum akhula emithini kwaye asetyenziswa kwizigulana ezinomhlaza, ngakumbi e-China nase Japan, ukomeleza amajoni omzimba. Ezinye zezona zinto ziphambili ezisebenzayo kumakhowa eReishi zii-Ergosterol Peroxide, iGanoderic acid, GPL, Linoleic acid, Oleic acid kunye nePalmitic acid

Iziphumo zeReishi / Ganoderma lucidum Ukusetyenziswa kweMushroom kwiCancer

Uhlalutyo lweemeta lwaBaphandi abasuka kwiYunivesithi yaseSydney

Abaphandi abavela kwiDyunivesithi yaseSydney e-Australia benze uphononongo olucwangcisiweyo lokuvavanya iziphumo zonyango lwe-Reishi / Ganoderma lucidum mushroom ekusindeni ixesha elide, ukuphendula nge-tumor, imisebenzi yamajoni omzimba kunye nomgangatho wobomi kwizigulana ezinomhlaza, kunye neziganeko ezimbi ezinxulumene nazo kunye nokusetyenziswa kwayo. Uhlalutyo, idatha evela kwizilingo ezi-5 ezilawulwa ngokungahleliwe yafunyanwa ngophando loncwadi kwiCochrane Central Register yeZilingo eziLawulwayo (CENTRAL), MEDLINE, EMBASE, NIH, AMED, CBM, CNKI, CMCC kunye ne-VIP Information / Chinese Database Scientific Database ngo-Okthobha u-2011. (Xingzhong Jin okqhubekayo, Cochrane Database Syst Rev., 2012)

Uhlalutyo lufumanise ukuba abaguli abafumene i-Reishi / Ganoderma lucidum mushroom ekhutshwe ecaleni kwe-chemo / radiotherapy kunokwenzeka ukuba baphendule ngokuqinisekileyo xa kuthelekiswa ne-chemo / radiotherapy yodwa. Nangona kunjalo, unyango ngeReishi / Ganoderma lucidum mushroom ekhutshwe yodwa ayinasibonelelo sinye njengoko kubonwe kunyango oludibeneyo. Izifundo ezine zifumanise ukuba abaguli abafumene ukukhutshwa kwe-mushroom yeReishi / Ganoderma lucidum ecaleni konyango lwabo babuphucule umgangatho wobomi xa kuthelekiswa nabo bafumana unyango lwabo lomhlaza kuphela. 

Abaphandi bagqibe kwelokuba iReishi/Ganoderma lucidum isicatshulwa sekhowa ayinakusetyenziswa njengonyango lokuqala lonyango. umhlaza. Nangona kunjalo, i-Reishi/Ganoderma lucidum isicatshulwa sekhowa inokulawulwa njengonyango lwe-adjuvant ecaleni konyango oluqhelekileyo ngenxa yamandla ayo okuphucula impendulo ye-tumor kunye nokuvuselela ukugonywa.

Impembelelo kaReishi / Ganoderma lucidum mushroom ekhutshwe kwizigulana ezineColorectal Adenomas

Isibhedlele saseYunivesithi i-Hiroshima eJapan siqhube uvavanyo lwezonyango kwizigulana ezingama-96 ezine-colorectal adenomas. zokuphuhliswa kwemihlaza yomhlaza. Izigulana ze-1.5 ezine-colorectal adenomas khange zixhaswe nge-Reishi / Ganoderma lucidum mushroom kwaye yathathelwa ingqalelo njengolawulo lwesifundo.

Uphononongo lufumanise ukuba ngelixa inani kunye nobukhulu be-adenomas bonyuswe kwiqela lolawulo, ezi zifunyenwe ukuba zehlisiwe kwizigulana ze-adenoma ezinemibala efumene isicatshulwa seReishi / Ganoderma lucidum mushroom. 

Ngokusekwe kwiziphumo zophando, abaphandi bagqiba kwelokuba iReishi / Ganoderma lucidum mushroom ekhutshwayo inokucinezela ukukhula kwe-adolo ye-adolo.

Impembelelo yeGanoderma Lucidum polysaccharides kwizigulana ezinomhlaza wemiphunga

Abaphandi abasuka kwiYunivesithi yaseMassey baqhuba isifundo sonyango kwizigulana ezingama-36 ezinomhlaza wemiphunga ophezulu ukuvavanya ifuthe lokuncedisa i-5.4 g / ngosuku Ganoderma Lucidum polysaccharides iiveki ezili-12. Iziphumo ezivela kolu phononongo zifumanise ukuba kuphela liqela elincinci lezi zigulana ezinomhlaza eziphendule kwi-Ganoderma Lucidum polysaccharides ngokudibeneyo ne-chemotherapy / i-radiotherapy kwaye yabonisa uphuculo oluthile kwimisebenzi yomzimba yokuzikhusela. 

Abaphandi bakwacebisa ukuba kufuneka uphando olukhulu oluchazwe kakuhle ukuze kuhlolwe ukusebenza kunye nokukhuseleka kweGanoderma Lucidum polysaccharides xa isetyenziswa yodwa okanye idityaniswe ne-chemotherapy / i-radiotherapy kwizigulana ezinomhlaza wemiphunga. (Yihuai Gao et al, J Med Ukutya., Ngehlobo 2005)

Impembelelo yeGanoderma Lucidum polysaccharides kwizigulana ezinomhlaza wamanqanaba aphezulu

Uphononongo lwangaphambili olwenziwe ngabaphandi abafanayo abavela kwiYunivesithi yaseMassey eNew Zealand bavavanye isiphumo sokusebenzisa i-1800 mg Ganoderma Lucidum polysaccharides kathathu ngemini kwiiveki ezili-12 kumzimba wokuzikhusela kwizigulana ezinomhlaza wamanqanaba angama-34. (Yihuai Gao okqhubekayo, Utyalo-mali lweImmunol, 2003)

Uphononongo lufumanise ukuba i-Ganoderma Lucidum polysaccharides iphucule iimpendulo zomzimba kwizigulana ezinomhlaza ophambili njengoko kulinganiswa ngamanqanaba e-cytokine (ukunyuka kwamanqanaba e-serum ye-IL-2, IL-6, kunye ne-IFN-gamma; kunye nokwehla kwe-IL-1 kunye nethumba amanqanaba e-necrosis (i-TNF-alpha)), i-lymphocyte (umhlaza wokulwa neseli yomzimba yokuzikhusela) ubalo kunye nokwanda kwemisebenzi yeseli yokubulala. Nangona kunjalo, bacebisa ezinye izifundo ukuvavanya ukhuseleko kunye nobutyhefu beGanoderma Lucidum polysaccharides ngaphambi kokucebisa ukusetyenziswa kwayo kwizigulana ezinomhlaza. 

Amakhowa eMaitake / Grifola frondosa

Maitake / Grifola frondosa Amakhowa akhula ngokwamaqela asezantsi emithini, ngakumbi i-oki. Ezinye zeekhompawundi ezisebenzayo zamakhowa ama-maitake zii-polysaccharides, i-ergosterol, i-magnesium, i-potassium kunye ne-phosphorus kunye neevithamini B1 kunye ne-B2. Amakhowa eMaitake ayasetyenziswa ukulwa namathumba, kunye neswekile esezantsi yegazi kunye nenqanaba lepidid. Ngokufanayo nama-mushroom aseTurkey omsila, amakhowa eMaitake nawo anenkqubo yomzimba yokuzikhusela ekhuthaza iipropathi.

Iziphumo zeMaitake mushroom extract Sebenzisa kuCancer

Impembelelo yokusetyenziswa kwamakhowa eMaitake ekusetyenzisweni kwezigulana ezinomhlaza kunye neMyelodysplastic Syndromes

Isigaba II sesifundo sonyango esenziwe ngabaphandi beenkonzo zoNyango oluHlanganisiweyo, eSikhumbuzweni seCettering Cancer Centre eMelika bavavanya iziphumo zokuxhasa isicatshulwa seMaitake mushroom (3 mg / kg) kwiiveki ezili-12 ekusebenzeni komzimba kwi-18 Myelodysplastic Syndromes (MDS ) abaguli. Uphononongo lufumanise ukuba isicatshulwa se-mushroom seMaitake sanyamezeleka kakuhle kwezi zigulana zinomhlaza kwaye sonyusa i-basal neutrophil kunye nomsebenzi we-monocyte kwi-vitro, iphakamisa amandla okugonyelwa kwe-Maitake mushroom mushroom kwi-MDS. (UKathleen M Wesa okqhubekayo, iCancer Immunol Immunother., 2015)

Impembelelo yeMaitake Mushroom Polysaccharide kwizigulana ezinomhlaza wamabele

Kwinqanaba le-I / II lokuvavanywa kweklinikhi okwenziwe ngabaphandi be-Integrative Medicine Service, iZiko leCancer Kettering Cancer e-US, bavavanya iimpembelelo ze-Maitake Mushroom Polysaccharide kwizigulana ezingama-34 ze-postmenopausal zomhlaza wamabele ezazingenasifo emva konyango lokuqala. . Izigulana zifumene i-0.1, i-0.5, i-1.5, i-3, okanye i-5 mg / kg yomlomo we-maitake mushroom okhutshwe kabini yonke imihla kwiiveki ze-3. (UGary Deng okqhubekayo, J Cancer Res Clin Oncol., 2009)

Uphononongo lufumanise ukuba ukulawulwa ngomlomo kwe-maitake mushroom polysaccharide isicatshulwa sasinxulunyaniswa neziphumo zokhuselo lomzimba kunye nezithintelo kwigazi lomda. Ngelixa ukonyusa iidosi zeMaitake mushroom izicatshulwa zonyuse iiparameter ezithile ze-immunologic, zabacinezela abanye. Ngenxa yoko, abaphandi baqaqambisa ukuba abaguli abanomhlaza kufuneka balumkiswe ngento yokuba izicatshulwa ze-mushroom zeMaitake zineziphumo ezibi ezinokuthi zixinezele kwaye zenze ukomelela komzimba kwiindawo ezahlukeneyo.

Isiphelo-Ngaba iReishi, iTurkey Tail kunye neMaitake Mushrooms zinokusetyenziswa njengonyango lokuqala loMhlaza?

Amakhowa afana neTurkey Tail, iReishi kunye ne-Maitake mushroom zibhekwa njengezinto zonyango. Izifundo ezahlukeneyo zibonisa ukuba amakhowa afana neTurkey Tail amakhowa anokuba namandla okuphucula amajoni omzimba kunye / okanye ukusinda kwizigulana ezinomhlaza ezifana nebele, i-colorectal, i-gastric kunye nomhlaza wemiphunga kunye nokunciphisa umngcipheko we-cancer njengomhlaza we-prostate, kunye noReishi / Amakhowa eGanoderma lucidum anokuba namandla okuphucula imisebenzi ye-immune ye-immune umhlaza izigulane kunye nokunciphisa umngcipheko wemihlaza efana ne-colorectal cancers. Nangona kunjalo, i-Turkey Tail, i-Reishi kunye ne-Maitake i-extracts ye-mushroom ayinakusetyenziswa njengonyango lokuqala lomhlaza, kodwa kuphela njenge-adjuvant ecaleni kwe-chemotherapy kunye ne-radiotherapy emva kokuvavanya ukusebenzisana kwabo nonyango. Kwakhona, ngelixa ukonyuka kwedosi ye-Maitake mushroom extracts yonyusa ezinye iiparamitha ze-immunologic kwizigulana ezinomhlaza, yacinezela abanye. Ulingo lwezonyango oluyilwe kakuhle ngakumbi luyafuneka ukuvavanya ukusebenza kunye nokhuseleko / ubuthi bazo zonke ezi nkowa zamayeza xa zisetyenziswa kunye neekhemotherapies ezithile kunye nolunye unyango lomhlaza.

Kukuphi ukutya okutyayo kwaye okuncedisayo kukuthatha sisigqibo osithathayo. Isigqibo sakho kufuneka sibandakanye ukuthathelwa ingqalelo kotshintsho lomhlaza kuhlobo lomhlaza, unyango oluqhubekayo kunye nezongezelelo, nakuphi na ukwaliwa, ulwazi ngobomi bakho, ubunzima, ukuphakama kunye nemikhwa.

Isicwangciso sesondlo somhlaza esivela kwi-addon asisekelwanga kukhangelo lwe-Intanethi. Isebenza ngokuzenzekelayo ukwenza izigqibo zakho kusekwe kwisayensi yemolekyuli ephunyezwe ngoososayensi kunye neenjineli zesoftware. Nokuba ukhathalele na ukuqonda iindlela ezisisiseko seemolekyuli okanye hayi - zokucwangciswa kwesondlo somhlaza ukuqonda kuyafuneka.

Qalisa NGOKU ngokucwangciswa kwesondlo ngokuphendula imibuzo ngegama lomhlaza, uguquko kwimfuza, unyango oluqhubekayo kunye nezincedisi, nakuphi na ukwaliwa, imikhwa, indlela yokuphila, iqela lobudala kunye nesini.

isampula-ingxelo

ISondlo esiSiqu soMhlaza!

Umhlaza uyatshintsha ngokuhamba kwexesha. Yenza ngokwezifiso kwaye uguqule isondlo sakho ngokusekwe kwisalathiso somhlaza, unyango, indlela yokuphila, ukhetho lokutya, i-allergies kunye nezinye izinto.


Izigulana ezinomhlaza zihlala zisebenza ngeendlela ezahlukeneyo iziphumo ebezingalindelekanga ezichaphazela umgangatho wobomi babo kwaye bajonge ezinye iindlela zonyango lomhlaza. Ukuthatha isondlo esifanelekileyo kunye nezongezelelo ezisekwe kuqwalaselo lwenzululwazi (ukunqanda ukuqikelela kunye nokukhetha okungahleliwe) sesona sixhobo sendalo somhlaza kunye neziphumo ebezingalindelekanga zonyango.


Iphononongwe ngokwenzululwazi ngu: UGqr

UChristopher R. Cogle, MD unguprofesa oqeshwe kwiYunivesithi yaseFlorida, iGosa eliPhezulu lezoNyango laseFlorida Medicaid, kunye noMlawuli we-Florida Health Policy Leadership Academy kwiZiko leBob Graham leNkonzo kaRhulumente.

Unokukufunda oku kwi

Lo msebenzi wawuyimfuneko kangakanani?

Cofa kwienkwenkwezi ukulinganisa!

Isilinganiso semilinganiselo 4.5 / 5. Inani lokuvota: 43

Akukho voti ukuza kuthi ga ngoku! Yiba ngowokuqala ukulinganisa le posi.

Njengoko ufumene esi sithuba siluncedo ...

Silandele kwimidiya yoluntu!

Siyaxolisa ukuba eli thunyelwe aliluncedo kuwe!

Masenze ngcono le post!

Sitshele indlela esinokuphucula ngayo le post?